Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 9, 1996, Pages 905-909

  Gross, Volker ^a   Andus, Tilo ^a   Caesar, Inka ^a   Bischoff, Stephan C ^c   Lochs, Herbert ^d   Tromm, Andreas ^e   Schulz, Hans Joachim ^f   Bär, Uwe ^g   Weber, Andrea ^e   Gierend, Michael ^e   Ewe, Klaus ^b   Schölmerich, Jürgen ^a,h   Adami, B ^e   Bauerle, H ^e   Fischbach, W ^e   Goebell, H ^e   Hoffmann, R ^e   Jakob, G ^e   Junge, U ^e   Lorenz Meyer, H ^e   Manns, M P ^e   May, B ^e   Malchow, H ^e   Riemann, J F ^e   Schmidt, C ^e   Seifert, E ^e   Tillinger, W ^e   Vogelsang, H ^e   Wordehoff D ^e   more..

^a UNIVERSITY OF REGENSBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Krankenanstalten Bergmannsheil B ^*

^f MARTIN LUTHER KRANKENHAUS   (Germany)

^g KLINIKUM OLDENBURG   (Germany)

^h UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Budesonide; Corticosteroids; Crohn's disease

Indexed keywords

BUDENOFALK; BUDESONIDE; GLUCOCORTICOID; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SKIN DISEASE; VISUAL DISORDER;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CROHN DISEASE; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREGNENEDIONES; PROSPECTIVE STUDIES; REMISSION INDUCTION;

EID: 10144246574     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Summers RW, Switz DM, Sessions JT, Becktel JM, Best WR, Kern F, et al.: National cooperative Crohn's disease study: results of drug treatment. Gastroenterology 1979, 77:847-869.
2. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, et al.: European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology 1984, 86:249-266.
3. Johansson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P: Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Resp Dis 1982, 63(suppl. 122):74-82.
4. Edsbacker S, Wollmer P, Nilsson A, Nilsson M: Pharmacokinetics and gastrointestinal transit of budesonide controlled ileal release (CIR) capsules. Gastroenterology 1993, 104:A695.
5. Matzen P and the Danish Budesonide Group: Budesonide enema in ulcerative colitis. A randomized dose-response trial with prednisolone enema as a positive control. Scand J Gastroenterol 1991, 26:1255-1230.
6. Danielsson A, Hellers G, Lyrenäs, Löfberg R, Nilsson A, Olsson O, et al.: A controlled trial of budesonide versus prednisolone retention enemas in active ulcerative colitis. Scand J Gastroenterol 1987, 22:987-992.
7. Danielsson A, Löfberg R, Persson T, Salde L, Schioler R, Suhr O, et al.: A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol 1992, 27:9-12.
8. Löfberg R, Ostergaard Thomsen O, Langholtz E, Schioler R, Danielsson A, Suhr O: Budesonide vs. prednisolone enema in active distal ulcerative colitis. A comparative eight week study. Gut 1993, 34(suppl. 1):40.
9. Bianchi Porro C, Campieri M, Bianchi P, Petrillo M, Gionchetti P, Campanini MC, Suhr O: Comparative trial of budesonide and methylprednisolone enemas in the treatment of ulcerative colitis. Gastroenterology 1992, 102:A595.
10. Lamers C, Meijef J, Engels L, Bos L, van Hogezand R, Driessen W, et at.: Comparative study of the topically acting glucocorticosteroid budesonide and 5-aminosalicylic acid enema therapy of proctitis and proctosigmoiditis, Gastroenterology 1991, 100(5):A223.
11. Wolman SL, Greenberg CR: Oral budesonide in active Crohn's disease: an initial experience. Gastroenterology 1991, 100:A263.
12. Löfberg R, Danielsson A, Salde L: Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther 1991, 7:611-616.
13. Roth M, Gross V, Ueberschaer B, Ewe K, Schölmerich J: Treatment of active Crohn's disease with an oral slow-release budesonide formulation. Am J Gastroenterol 1993, 88:968-969.
14. Rutgeerts P, Loefberg R, Malchow H, Lamers C, Olaison C, Jewell D, et al.: A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994, 331:842-845.
15. Greenberg CR, Feagan BD, Martin F, Sutherland LR, Thomson A, Williams CN, et al.: Oral budesonide for active Crohn's disease. N Engl J Med 1994, 331:836-841.
16. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson ABR, Williams CN, et al.: Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Gastroenterology 1996, 110:45-51.
17. Caesar I, Gross V, Roth M, Andus T, Schmidt C, Raedsch R, et al.: Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Z Gastroenterol 1995, 33:247-259.
18. Novacek G, Kleinberger M, Vogelsang H, Mosser G, Lochs H: Budesonide in glucocorticoid dependent chronic active Crohn's disease: a pilot study. Z Gastroenterol 1995, 33:251-254.